153 Mycetoma eumycetoma and actinomycetoma Mahreen Ameen and Wanda Sonia Robles Evidence Levels: A Double-blind study B Clinical trial ≥ 20 subjects C Clinical trial < 20 subjects D Series ≥ 5 subjects E Anecdotal…
97 Hereditary angioedema Malcolm W. Greaves Evidence Levels: A Double-blind study B Clinical trial ≥ 20 subjects C Clinical trial < 20 subjects D Series ≥ 5 subjects E Anecdotal case reports Classic hereditary angioedema…
73 Erythema nodosum Robert A. Allen Evidence Levels: A Double-blind study B Clinical trial ≥ 20 subjects C Clinical trial < 20 subjects D Series ≥ 5 subjects E Anecdotal case reports (Courtesy of Herbert…
137 Lymphangioma circumscriptum Patrick O.M. Emanuel and Ben Tallon Evidence Levels: A Double-blind study B Clinical trial ≥ 20 subjects C Clinical trial < 20 subjects D Series ≥ 5 subjects E Anecdotal case reports…
232 Syringomata James A.A. Langtry Evidence Levels: A Double-blind study B Clinical trial ≥ 20 subjects C Clinical trial < 20 subjects D Series ≥ 5 subjects E Anecdotal case reports Syringomata are benign appendageal…
95 Hailey–Hailey disease Robin A.C. Graham-Brown and Susan M. Burge Evidence Levels: A Double-blind study B Clinical trial ≥ 20 subjects C Clinical trial < 20 subjects D Series ≥ 5 subjects E Anecdotal case…
64 Epidermal nevi Jeffrey M. Weinberg Evidence Levels: A Double-blind study B Clinical trial ≥ 20 subjects C Clinical trial < 20 subjects D Series ≥ 5 subjects E Anecdotal case reports (Courtesy of Neil…
128 Lichen planopilaris Anwar Al Hammadi and Eric Berkowitz Evidence Levels: A Double-blind study B Clinical trial ≥ 20 subjects C Clinical trial < 20 subjects D Series ≥ 5 subjects E Anecdotal case reports…
71 Erythema elevatum diutinum Pamela Fiandeiro, Emma Benton and Ian Coulson Evidence Levels: A Double-blind study B Clinical trial ≥ 20 subjects C Clinical trial < 20 subjects D Series ≥ 5 subjects E Anecdotal…
249 Xeroderma pigmentosum Deborah Tamura, Kenneth H. Kraemer and John J. DiGiovanna Evidence Levels: A Double-blind study B Clinical trial ≥ 20 subjects C Clinical trial < 20 subjects D Series ≥ 5 subjects E…
